What are the risks of choosing the wrong laboratory automation vendor?

Choosing the wrong laboratory automation vendor puts your laboratory’s data quality, regulatory standing, and operational budget at serious risk. For labs working with persistent organic pollutants, PFAS, dioxins, or pesticides, a mismatched vendor can mean failed method validations, contaminated results, and costly system replacements. The questions below unpack each of these risks in detail so you can make a more informed vendor selection decision.

What happens when a lab automation vendor can’t support your methods?

When a laboratory automation vendor cannot support your specific analytical methods, your workflows stall, your staff loses time troubleshooting unsupported configurations, and your data quality suffers. Method support is not just about hardware compatibility, it covers software flexibility, application-specific programming, access to validated protocols, and the vendor’s ability to adapt systems to evolving regulatory standards such as EPA or CEN methods.

In practice, method support gaps often surface after installation. A vendor may supply a capable instrument but lack the application expertise to configure it for your matrix types, whether that is food, soil, sludge, water, or air. For laboratories analyzing complex environmental contaminants, this is particularly damaging. Purification sequences for dioxins or PCBs are highly matrix-dependent, and a vendor without deep domain knowledge cannot provide the pre-installation programming or application testing that makes automated cleanup reliable from day one.

The consequences compound over time. Staff spend hours attempting manual workarounds, validation timelines stretch, and sample throughput drops. In high-volume contract testing environments, that directly translates to lost revenue and client confidence. A vendor who cannot grow with your method portfolio is not a long-term partner, they are a liability.

How does a poor vendor choice affect regulatory compliance?

A poor laboratory automation vendor choice can directly undermine regulatory compliance by delivering systems that are not configured to meet applicable analytical standards, lack the traceability documentation required for accreditation, or cannot be validated against methods recognized by regulatory bodies. For ISO 17025-accredited laboratories, this is an existential risk, non-conforming instrumentation can trigger audit findings or jeopardize accreditation status entirely.

Regulatory compliance in environmental contaminant analysis is not a static target. EU food safety legislation, EPA monitoring programs, and international frameworks for PFAS and dioxin testing are updated regularly. A vendor without active engagement in these regulatory developments will leave your laboratory running outdated configurations that no longer satisfy current requirements.

There is also the matter of documentation and reporting. Accredited laboratories require full traceability from sample intake to final result. If your automation vendor cannot supply calibration records, system qualification data, or software audit trails that satisfy ISO 17025 requirements, your laboratory carries the compliance burden alone, an unsustainable position in high-stakes analytical environments.

What are the hidden costs of switching laboratory automation vendors?

The hidden costs of switching laboratory automation vendors extend well beyond the price of new equipment. They include staff retraining, method revalidation, downtime during system changeover, data migration challenges, and the loss of institutional knowledge built around a previous platform. These costs are frequently underestimated during vendor evaluation and can significantly exceed the visible purchase price of a replacement system.

Revalidation and downtime costs

When you replace an automated sample preparation system, every method previously validated on that platform must be revalidated on the new one. For laboratories holding ISO 17025 accreditation, this is not optional, it is a formal requirement. Revalidation across multiple analyte groups, such as PCBs, PBDEs, and pesticides, can take weeks or months depending on matrix complexity, pulling analytical staff away from billable work and delaying client deliverables.

Retraining and workflow disruption

Automation platforms differ substantially in their operating logic, software interfaces, and maintenance requirements. Staff who have built proficiency with one system must invest significant time learning a new one. During this transition period, error rates rise, throughput drops, and experienced analysts spend time on basic operational tasks rather than high-value analytical work. In smaller laboratories, this disruption can affect client relationships and contract renewals.

The total cost of a vendor switch, when all these factors are accounted for, often makes a careful upfront vendor selection decision far more economical than correcting a poor one later.

How can the wrong vendor increase contamination and solvent waste risks?

The wrong laboratory automation vendor can increase contamination and solvent waste risks by supplying systems that lack inert flow paths, use materials incompatible with target analytes, or rely on design principles that allow sample carryover between runs. For laboratories analyzing trace-level contaminants such as PFAS or dioxins, these are not minor inconveniences, they produce false positives, compromise data integrity, and generate significant quantities of hazardous waste.

Contamination risk in automated sample preparation is closely tied to system design. Systems where samples come into direct contact with shared internal components create carryover pathways that are difficult to eliminate through cleaning protocols alone. In contrast, well-designed systems isolate samples from the instrument’s internal surfaces, removing cross-contamination as a variable entirely. A vendor who does not understand or address this design requirement is unsuitable for laboratories running sensitive environmental analyses.

Solvent waste is an equally important consideration. Many legacy or poorly specified automated systems consume large volumes of organic solvents per sample run, often including dichloromethane, a hazardous solvent with significant health and environmental implications. Vendors who have not invested in green chemistry approaches to automated cleanup will leave laboratories with higher solvent procurement costs, greater waste disposal obligations, and a larger environmental footprint. As sustainability expectations from regulators and clients increase in 2026, this is a risk that carries both financial and reputational consequences.

Laboratories evaluating automated sample preparation systems should specifically ask vendors how their systems eliminate cross-contamination and what solvent volumes are required per sample across different matrices.

What should laboratories evaluate before committing to an automation vendor?

Before committing to a laboratory automation vendor, laboratories should evaluate the vendor’s application expertise in their specific analyte and matrix areas, the technical design of the systems offered, the level of pre- and post-sale support provided, regulatory alignment, and the vendor’s long-term stability as a partner. A structured evaluation process protects against both immediate performance failures and longer-term strategic mismatches.

Application expertise: Does the vendor have demonstrated experience with your target analytes, dioxins, PCBs, PFAS, pesticides, and your sample matrices? Can they provide validated protocols or peer-reviewed references for your application area?
System design and chemistry compatibility: Are the systems designed with inert flow paths? Are they free of materials that adsorb or degrade target analytes? Are solvent volumes minimized, and is dichloromethane eliminated from the workflow?
Regulatory and method alignment: Are the systems configurable to EPA, CEN, or ISO methods relevant to your work? Can the vendor support method validation and provide the documentation required for ISO 17025 accreditation?
Pre-installation and commissioning support: Does the vendor configure and test the system for your specific application before delivery, or does your laboratory carry that burden?
Training and ongoing technical support: What training is included? Is there accessible technical support when methods need adjustment or issues arise post-installation?
Vendor stability and network: Is the vendor an established player with a reliable supply chain, manufacturer relationships, and a track record of long-term customer support?

Asking these questions systematically, rather than focusing primarily on purchase price, is the most reliable way to avoid the operational, compliance, and financial risks that come with a mismatched automated sample preparation vendor selection.

How DSP-Systems helps laboratories avoid the wrong vendor choice

DSP-Systems is a specialized laboratory automation partner built specifically for laboratories analyzing environmental contaminants. Rather than offering generic instrumentation, DSP-Systems provides targeted solutions backed by deep application expertise in dioxins, PCBs, PFAS, PBDEs, and pesticides across a wide range of matrices. Here is how DSP-Systems addresses each of the risks covered in this article:

Method support from day one: Systems are pre-configured and tested for your specific application before installation, with configuration aligned to EPA and CEN standards.
Regulatory compliance: DSP-Systems works closely with ISO 17025-accredited laboratories and provides the documentation, method development support, and validation expertise needed to maintain accreditation.
Contamination elimination: The GO-EHT and SPE2000 systems are designed so samples never come into direct contact with the system, removing cross-contamination as a risk entirely.
Solvent reduction: All systems are engineered to use less than 100 mL of organic solvent per sample, with no dichloromethane required, reducing both waste disposal costs and environmental impact.
Long-term partnership: DSP-Systems offers training courses, turn-key lab setups, ongoing technical support, and outsourced analytical services, making them a partner across your laboratory’s full lifecycle, not just a supplier.

If you are evaluating automated sample preparation systems and want to speak with a specialist who understands your application, contact DSP-Systems to discuss your laboratory’s specific requirements.

Veelgestelde vragen

How do I know if my current laboratory automation vendor is already putting my compliance at risk?

Start by auditing whether your vendor has provided complete calibration records, system qualification data, and software audit trails that satisfy ISO 17025 requirements. If your laboratory is compensating for documentation gaps by generating its own traceability records, or if staff are regularly troubleshooting unsupported method configurations, these are strong indicators of a misaligned vendor relationship. Scheduling an internal review against your accreditation body’s requirements — before your next external audit — is the most practical first step.

What is the best way to compare laboratory automation vendors when our analyte portfolio spans multiple contaminant classes?

Request application-specific demonstrations rather than general product presentations — ask each vendor to run or document a validated protocol for your most complex matrix and analyte combination, such as dioxins in sludge or PFAS in food. Peer-reviewed publications, accredited laboratory references, and pre-installation test data are more reliable indicators of genuine capability than brochures or sales claims. Evaluating vendors side by side on a defined set of application criteria, rather than on price alone, will surface meaningful performance and support differences.

Can we validate a new automated sample preparation system faster if the vendor pre-configures it for our methods before delivery?

Yes, significantly. When a vendor pre-configures and application-tests a system against your specific analytes, matrices, and regulatory method requirements before shipment, your laboratory enters the validation process with a working baseline rather than a blank instrument. This reduces the number of optimization cycles required during on-site validation and can compress overall validation timelines considerably. For ISO 17025-accredited laboratories, this also means commissioning documentation arrives with the system rather than being built from scratch post-installation.

What questions should we ask a vendor specifically about cross-contamination prevention in automated sample cleanup?

Ask whether samples ever come into direct contact with shared internal instrument components, and if so, what cleaning validation data exists to demonstrate carryover is eliminated between runs. Request to see blank results run after high-concentration samples across your target analyte classes. For trace-level analyses such as PFAS or dioxins, the only fully reliable design approach is one where samples are isolated from the instrument’s internal surfaces entirely — so understanding the system’s physical architecture, not just its cleaning protocol, is essential.

How should a laboratory budget for a vendor switch if they are already locked into an underperforming system?

Build a full cost model that includes method revalidation labor, staff retraining time, system downtime and its impact on billable throughput, data migration, and any consumable or infrastructure changes required by the new platform. In many cases, this total cost is two to four times the visible equipment price, which is why phasing the transition — beginning with the highest-risk or highest-volume application areas — can make the switch more financially manageable. Engaging the prospective new vendor early to scope these transition requirements is a practical way to develop realistic budget figures before committing.

Are there specific red flags to watch for during a vendor sales process that signal poor post-sale support?

Watch for vendors who cannot provide direct references from accredited laboratories running similar applications, who are vague about what is included in commissioning versus what is billed separately, or who cannot name a dedicated application specialist for your contaminant class. Overly generic responses to method-specific questions — particularly around matrix variability, regulatory method alignment, or revalidation support — are also strong indicators that post-sale technical depth will be limited. A vendor’s willingness to discuss your specific application in detail before the sale is usually a reliable predictor of how they will perform after it.

How is the regulatory landscape for PFAS and dioxin analysis changing in 2025–2026, and what does that mean for vendor selection?

Regulatory requirements for PFAS and dioxin analysis are tightening across multiple jurisdictions, with the EU expanding monitored compound lists, lowering maximum residue limits, and increasing method specificity requirements under food safety and environmental frameworks. For vendor selection, this means prioritizing partners who are actively tracking these regulatory developments and can demonstrate a pathway to updating system configurations as new method requirements come into force. A vendor without a clear process for regulatory monitoring and software or protocol updates will require your laboratory to absorb that adaptation burden internally — an increasingly costly position as the pace of regulatory change accelerates.

Gerelateerde artikelen

Deze inhoud is gegenereerd met behulp van AI en kan fouten bevatten.